Columbia, Maryland, November 9, 2018 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in events at prominent diabetes and healthcare conferences this Fall. The list of events is as follows:
18th Annual Diabetes Technology Meeting
November 8-10, 2018, Bethesda North Marriott & Conference Center, Bethesda, MD
Welldoc Medical Director Mansur E. Shomali, MD, CM will present the poster “Determinants for Digital Health Engagement” on November 9 at 4:15 to 6:30 p.m. ET.
Economic Alliance for Michigan (EAM) Health Purchaser Forum
November 9th, 2018, The GMRENCEN Conference Center, Detroit, MI
Welldoc Executive Vice President of Enterprise Solutions Laurel Pickering will present “The Power and Promise of Digital Health to Engage Customers, Improve Health and Lower Costs” at 1:15 p.m. CST.
American Diabetes Association: Diabetes is Primary
November 13th, 2018, Sheppard Pratt Conference Center, Baltimore, MD
Welldoc Medical Director Mansur E. Shomali, MD, CM, will present “How to Use the Type 2 Diabetes Treatment Algorithm” at 11:00 a.m. ET.
Merck – World Diabetes Day
November 14th, 2018, Digital Dialogue Transmitted Live
Welldoc Executive Vice President of Enterprise Solutions Laurel Pickering with Diabetes Research Center at Mills-Peninsula Medical Center’s Medical Director David Klonoff will present “The Future of Digital Technology in the Treatment of Type 2 Diabetes Patients” at 7:05 a.m. EST.
Clinically Validated Digital Therapeutics Summit
December 3-4th, 2018, The Revere Hotel, Boston, MA
Welldoc Chief Strategy Officer Anand Iyer will present “Sweetening the Economic Value Proposition of Digital Therapeutics: A Real-World Study and Method to Translate Clinical Outcomes into Cost Savings for Diabetes” on December 4, 2018 at 9:00 a.m. EST.
Welldoc also participated in the AADE Maryland CB Annual Conference: Digesting Diabetes on October 26, 2018 at the Maritime Institute Conference Center in Baltimore, MD. Director of Clinical Innovation Janice MacLeod, MA, RDN, LDN, CDE, and Senior Manager of Clinical and Product Content Design Catherine Brown presented, “Sorting Out the Nutrition Myths with Critical Thinking – Individualized Evidence Based Nutrition Guidelines for Diabetes.”
Welldoc® is the leading digital health company revolutionizing chronic disease management to help transform lives. Our groundbreaking technology is guiding individuals through the complicated journey of living with chronic diseases, with a goal of improving their health and helping them to be more balanced. We are the first digital health company based on a life science business model, and our foundation is built on randomized clinical trials that demonstrate significant clinical outcomes. We have mastered diabetes management by taking an aggressive and innovative approach that utilizes sophisticated logic and precise algorithms, and integrates the most advanced mobile technology, behavioral insight, and diabetes education for those living with type 2 diabetes. Our FDA-cleared, proven digital therapeutic, BlueStar®, provides real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personal. Our clinical evidence shows a 1.7 to 2.0-point mean A1C reduction for adults living with type 2 diabetes who used BlueStar®. For more information, visit www.welldoc.com.